HeartSciences (NASDAQ:HSCS – Get Free Report) and Clover Health Investments (NASDAQ:CLOV – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.
Valuation and Earnings
This table compares HeartSciences and Clover Health Investments”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| HeartSciences | N/A | N/A | -$8.77 million | ($4.94) | -0.56 |
| Clover Health Investments | $1.92 billion | 1.44 | -$85.55 million | ($0.12) | -43.83 |
Analyst Recommendations
This is a summary of current ratings and recommmendations for HeartSciences and Clover Health Investments, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| HeartSciences | 1 | 0 | 1 | 0 | 2.00 |
| Clover Health Investments | 1 | 3 | 1 | 0 | 2.00 |
HeartSciences currently has a consensus target price of $8.00, suggesting a potential upside of 186.74%. Clover Health Investments has a consensus target price of $3.82, suggesting a potential downside of 27.44%. Given HeartSciences’ higher possible upside, equities analysts clearly believe HeartSciences is more favorable than Clover Health Investments.
Volatility & Risk
HeartSciences has a beta of 1.78, suggesting that its share price is 78% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.41, suggesting that its share price is 141% more volatile than the S&P 500.
Insider and Institutional Ownership
17.2% of HeartSciences shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 4.9% of HeartSciences shares are held by insiders. Comparatively, 23.5% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
This table compares HeartSciences and Clover Health Investments’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| HeartSciences | N/A | -333.50% | -140.18% |
| Clover Health Investments | -2.58% | -16.52% | -9.28% |
Summary
Clover Health Investments beats HeartSciences on 7 of the 11 factors compared between the two stocks.
About HeartSciences
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Receive News & Ratings for HeartSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartSciences and related companies with MarketBeat.com's FREE daily email newsletter.
